Idiopathic Short Stature (ISS)Symptoms, Doctors, Treatments, Advances & More
Learn About Idiopathic Short Stature (ISS)
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
St. Christopher's Pediatric Associates Radiology - E. Erie Avenue
. Dr. Contrucci is rated as an Advanced provider by MediFind in the treatment of Idiopathic Short Stature (ISS). Her top areas of expertise are Tracheobronchopathia Osteoplastica, Scoliosis, Short Stature (Growth Disorders), and Familial Short Stature (FSS).
St. Christopher's Pediatric Associates Endocrinology - E. Erie Avenue
. Dr. Kubicky is rated as an Advanced provider by MediFind in the treatment of Idiopathic Short Stature (ISS). Her top areas of expertise are Acanthosis Nigricans, Type A Insulin Resistance Syndrome, Pseudohypoparathyroidism, and Albright's Hereditary Osteodystrophy.
St. Christopher's Pediatric Associates Endocrinology - E. Erie Avenue
. Dr. Suarez is rated as an Advanced provider by MediFind in the treatment of Idiopathic Short Stature (ISS). Her top areas of expertise are Short Stature (Growth Disorders), Idiopathic Short Stature (ISS), Familial Short Stature (FSS), and Precocious Puberty.
Summary: This basket trial will enroll prepubertal children and adolescents with clinically diagnosed and genetically confirmed (if applicable) TS, SHOX-D, SGA, or ISS between ages of ≥2 and \<18 years with open growth plates. The purpose of the study is to see how well treatment with once-weekly lonapegsomatropin works compared to treatment with daily somatropin. Approximately 186 participants will be dis...
Summary: This is a multicenter, randomized, open-label, active-controlled Phase III clinical trial to evaluate the efficacy and safety of Inpegsomatropin injection，once a week，compared with recombinant human growth hormone (rhGH) in children with idiopathic short stature (ISS). It plans to enroll 300 children with ISS, who will be randomized , stratified by gender and age, and assigned to either the experi...